These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37419622)

  • 1. Interleukin (IL)-17 Versus IL-23 Inhibitors: Which Is Better to Treat Patients With Moderate-to-Severe Psoriasis and Mild Psoriatic Arthritis in Dermatology Clinics?
    Agüero R; Woodbury MJ; Lee K; Johnsson HJ; Merola JF; Armstrong AW
    J Rheumatol; 2023 Nov; 50(Suppl 2):11-13. PubMed ID: 37419622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prologue: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 Annual Meeting.
    Gottlieb AB; Armstrong AW; FitzGerald O; Gladman DD
    J Rheumatol; 2023 Nov; 50(Suppl 2):1-3. PubMed ID: 37419627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does previous use of tumour necrosis inhibitors change the therapeutic effect of interleukin (IL)-17 or IL-12/23 inhibitors on psoriasis and psoriatic arthritis? Results of a systematic review.
    Xie Y; Liu Y
    Clin Exp Dermatol; 2022 Sep; 47(9):1627-1635. PubMed ID: 35466472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database.
    Pina Vegas L; Penso L; Claudepierre P; Sbidian E
    JAMA Dermatol; 2022 May; 158(5):513-522. PubMed ID: 35319735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Psoriasis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.
    Duffin KC; Mazzuoccolo LD; Cura MJ; Esposito M; Fernandez AP; Gisondi P; Giunta A; Hillary T; Piaserico S; Solomon JA; Merola JF
    J Rheumatol; 2023 Jan; 50(1):131-143. PubMed ID: 36319014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies.
    Novelli L; Chimenti MS; Chiricozzi A; Perricone R
    Autoimmun Rev; 2014 Jan; 13(1):64-9. PubMed ID: 24021172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of IL-23 Inhibitors for the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review.
    Yang K; Oak ASW; Elewski BE
    Am J Clin Dermatol; 2021 Mar; 22(2):173-192. PubMed ID: 33301128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ustekinumab for the treatment of psoriasis and psoriatic arthritis: a drug evaluation and literature review.
    Thibodaux RJ; Triche MW; Espinoza LR
    Expert Opin Biol Ther; 2018 Jul; 18(7):821-827. PubMed ID: 29949399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can Early Aggressive Treatment of Psoriasis Prevent Psoriatic Arthritis? A Debate at the GRAPPA Annual Meeting.
    Soriano ER; Ogdie A
    J Rheumatol; 2023 Nov; 50(Suppl 2):8-10. PubMed ID: 37527866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report of the IDEOM Meeting Adjacent to the GRAPPA 2023 Annual Meeting.
    Ball GD; Yee D; Zhang AJ; Perez-Chada LM; Strand V; Merola JF; Armstrong AW; Gottlieb AB
    J Rheumatol; 2024 Jul; ():. PubMed ID: 39009383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guselkumab: the First Selective IL-23 Inhibitor for Active Psoriatic Arthritis in Adults.
    Boehncke WH; Brembilla NC; Nissen MJ
    Expert Rev Clin Immunol; 2021 Jan; 17(1):5-13. PubMed ID: 33251833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report of the Skin Research Workgroups from the GRAPPA 2018 Annual Meeting.
    Perez-Chada LM; Merola JF; Armstrong AW; Gottlieb AB
    J Rheumatol Suppl; 2019 Jun; 95():28-32. PubMed ID: 31154401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guselkumab, tildrakizumab, and risankizumab in a real-world setting: drug survival and effectiveness in the treatment of psoriasis and psoriatic arthritis.
    Elgaard CDB; Iversen L; Hjuler KF
    J Dermatolog Treat; 2023 Dec; 34(1):2133531. PubMed ID: 36200762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Peripheral Arthritis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.
    Leung YY; Korotaeva TV; Candia L; Pedersen SJ; Bautista Molano W; Ruderman EM; Bisoendial R; Perez-Alamino R; Olsder W; Möller B; Grazio S; Gudu T; Mody GM; Pineda C; Raffayova H; Rohekar S; Goldenstein-Schainberg C; Gutierrez Urena SR; Casasola Vargas JC; Meghnathi B; Prasad R; Richette P; Miranda JRS; Malliotis N; Lindqvist U; Simon D; Ezeonyeji A; Soriano ER; FitzGerald O
    J Rheumatol; 2023 Jan; 50(1):119-130. PubMed ID: 36243409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic literature review and meta-analysis.
    Eder L; Mylvaganam S; Pardo Pardo J; Petkovic J; Strand V; Mease P; Colaco K
    Lancet Rheumatol; 2023 Dec; 5(12):e716-e727. PubMed ID: 38251562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Axial Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.
    Lubrano E; Chan J; Queiro-Silva R; Cauli A; Goel N; Poddubnyy D; Nash P; Gladman DD
    J Rheumatol; 2023 Feb; 50(2):279-284. PubMed ID: 36318999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in the Diagnosis and Assessment of Psoriatic Arthritis.
    Ogdie A; Lindsay CA; Mease PJ; Duffin KC; Rosen CF; Siebert S
    J Rheumatol; 2022 Jun; 49(6 Suppl 1):64-67. PubMed ID: 35428713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ixekizumab for treatment of adults with moderate-to-severe plaque psoriasis and psoriatic arthritis.
    Vu TT; Gooderham M; Papp K
    Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1423-1433. PubMed ID: 27690669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interleukin-17 pathway in psoriasis and psoriatic arthritis: disease pathogenesis and possibilities of treatment.
    Frleta M; Siebert S; McInnes IB
    Curr Rheumatol Rep; 2014 Apr; 16(4):414. PubMed ID: 24570394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances and Controversies in Our Understanding of Guttate and Plaque Psoriasis.
    Duffin KC; Hwang ST; Krueger JG
    J Rheumatol; 2023 Nov; 50(Suppl 2):4-7. PubMed ID: 37657796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.